((SL Advertiser)) New treatment option for those with chronic obstructive pulmonary disease or COPD. To learn more, go to ...

Sure, having a cold or respiratory infection can temporarily make it harder to breathe. But if excessive coughing and ...

Chronic obstructive pulmonary disease is one of the world’s leading causes of death - more than 300 million live with the ...

For those who have COPD and don’t know where to begin, the My COPD Checklist is your first port of call; one that can point ...

Two posters presented at the CHEST 2024 annual meeting underscore the importance of early identification and treatment of ...

Grace Anne Dorney Koppel was told she only had a few years left after her 2001 COPD diagnosis. Now, the couple provides the ...

There are several tests that doctors can use to diagnose and monitor COPD. Let's take a look at what abnormal values for ...

Its growth is attributed to the introduction of new treatments. The chronic obstructive pulmonary disease (COPD) market is ...

A recent seminar at the Allahabad Medical Association focused on acute exacerbation management of Chronic Obstructive Pulmonary Disease (COPD). Expert Dr. Shubham Agrawal discussed treatment protocols ...

Currently, COPD-marketed therapy leaders include GSK’s Trelegy Ellipta, which is set to grow in sales to $2.16bn by 2033.

Klaus Rabe, MD, PhD, chest physician and professor of medicine, University of Kiel, discusses the potential of tailored treatment strategies and the importance of smoking cessation.

A recent study found that the respiratory and non-respiratory symptom burden in patients with COPD is high when compared with ...